The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients.
Abstract
Objectives To test the usefulness of procalcitonin serum level for the reduction of antibiotic consumption in intensive care unit patients. Design Single-center, prospective, randomized controlled study. Setting Five intensive care units from a tertiary teaching hospital. Patients All consecutive adult patients hospitalized for >48 hrs in the intensive care unit during a 9-month period. Interventions Procalcitonin serum level was obtained for all consecutive patients suspected of developing infection either on admission or during intensive care unit stay. The use of antibiotics was more or less strongly discouraged or recommended according to the Muller classification. Patients were randomized into two groups: one using the procalcitonin results (procalcitonin group) and one being blinded to the procalcitonin results (control group). The primary end point was the reduction of antibiotic use expressed as a proportion of treatment days and of daily defined dose per 100 intensive care unit days using a procalcitonin-guided approach. Secondary end points included: a posteriori assessment of the accuracy of the infectious diagnosis when using procalcitonin in the intensive care unit and of the diagnostic concordance between the intensive care unit physician and the infectious-disease specialist. Measurements and main results There were 258 patients in the procalcitonin group and 251 patients in the control group. A significantly higher amount of withheld treatment was observed in…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Early administration of appropriate antimicrobials is one of the most effective interventions to reduce mortality in patients with sepsis (96-98).”
From Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021. (2021) · cites this paper as [96]
In the citing paper
“A meta-analysis of the three trials (n = 1769 ICU patients) found no difference in short-term mortality (RR 0.99; 95% CI 0.86–1.15)”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [130]
In the citing paper
“or length of hospitalisation (MD 7.00 days; 95% CI −26.24 to 12.24).”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [130]
In the citing paper
“Long-term mortality, readmission rates and hospital-free days were not reported in any of the trials, and no relevant studies on the costs associated with use of procalcitonin were found.”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [130]
In the citing paper
“length of ICU stays (MD 0.19 days; 95% CI −0.98 to 1.36)”
From Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 (2021) · cites this paper as [130]
Citations
Cites
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Dellit, T. H., Owens, R. C., McGowan, J. E., Gerding, D. N., Weinstein, R. A., Burke, J. P., Huskins, W. C., Paterson, D. L., Fishman, N. O., Carpenter, C. F., et al. (2007) · Clinical Infectious Diseases · doi:10.1086/510393 · Cited by 3,362
Bouadma, L., Luyt, C.-E., Tubach, F., Cracco, C., Alvarez, A., Schwebel, C., Schortgen, F., Lasocki, S., Veber, B., Dehoux, M., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61879-1 · Cited by 1,183
Christ-Crain, M., Jaccard-Stolz, D., Bingisser, R., Gencay, M. M., Huber, P. R., Tamm, M., & Müller, B. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15591-8 · Cited by 1,096
Moreno, R., Vincent, J.-L., Matos, R., Mendonça, A., Cantraine, F., Thijs, L., Takala, J., Sprung, C., Antonelli, M., Bruining, H., et al. (1999) · Intensive Care Medicine · doi:10.1007/s001340050931 · Cited by 1,058
Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia: A Randomized Trial
Christ-Crain, M., Stolz, D., Bingisser, R., Müller, C., Miedinger, D., Huber, P. R., Zimmerli, W., Harbarth, S., Tamm, M., & Müller, B. (2006) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200512-1922oc · Cited by 884
Goldmann, D. A. (1996) · JAMA · doi:10.1001/jama.1996.03530270074035 · Cited by 753
Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit
Müller, B., Becker, K. L., Schächinger, H., Rickenbacher, P. R., Huber, P. R., Zimmerli, W., & Ritz, R. (2000) · Critical Care Medicine · doi:10.1097/00003246-200004000-00011 · Cited by 628
Use of Procalcitonin to Shorten Antibiotic Treatment Duration in Septic Patients
Nobre, V., Harbarth, S., Graf, J.-D., Rohner, P., & Pugin, J. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1238oc · Cited by 605
Cited by
Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Intensive Care Medicine · doi:10.1007/s00134-021-06506-y · Cited by 5,082
Barlam, T. F., Cosgrove, S. E., Abbo, L. M., MacDougall, C., Schuetz, A. N., Septimus, E. J., Srinivasan, A., Dellit, T. H., Falck-Ytter, Y. T., Fishman, N. O., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/ciw118 · Cited by 3,061
“the use of PCT to avoid initiation of antibiotics in the critically ill ICU population when the PCT result is negative [174, 175].”
MethodSurviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock 2021.
Evans, L., Rhodes, A., Alhazzani, W., Antonelli, M., Coopersmith, C. M., French, C., Machado, F. R., Mcintyre, L., Ostermann, M., Prescott, H. C., et al. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005337 · Cited by 2,935
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Brown, E., Charani, E., Fenelon, L., Gould, I. M., Holmes, A., Ramsay, C. R., Wiffen, P. J., & Wilcox, M. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub3 · Cited by 1,864
Interventions to improve antibiotic prescribing practices for hospital inpatients
Davey, P., Marwick, C. A., Scott, C. L., Charani, E., McNeil, K., Brown, E., Gould, I. M., Ramsay, C. R., & Michie, S. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003543.pub4 · Cited by 1,068
Metadata
- Authors
- Layios, N., Lambermont, B., Canivet, J.-L., Morimont, P., Preiser, J.-C., Garweg, C., Ledoux, D., Frippiat, F., Piret, S., Giot, J.-B., Wiesen, P., Meuris, C., Massion, P., Leonard, P., Nys, M., Lancellotti, P., Chapelle, J.-P., & Damas, P.
- Affiliations
- University of Liège (BE)
- ORCID
- Venue
- Critical Care Medicine
- Published
- 2012-08
- Volume
- 40
- Issue
- 8
- Pages
- 2304-2309
- ISSN
- 0090-3493 (ISSN-L)
- OpenAlex
- W1985812045
- Semantic Scholar
- ab2e827068c7039d51d3dde243f3a59a9e448874
- Cited by
- 137
- References
- 19
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 13 · 2023: 17 · 2022: 3 · 2021: 8 · 2020: 8 · 2019: 9 · 2018: 8 · 2017: 20 · 2016: 6 · 2015: 12 · 2014: 6 · 2013: 15 · 2012: 3
- FWCI
- 8.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Care Medicine (publishedVersion)
- PubMed (publishedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- ORBi (University of Liège) (submittedVersion)
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Nosocomial Infections in ICU
- Keywords
- procalcitonin, antibiotic stewardship, antibiotic use reduction, intensive care unit patients, infection diagnosis, Müller classification, diagnostic accuracy, antibiotic de-escalation, intensive care physicians, sepsis, nosocomial infections, infection biomarkers, defined daily doses, cost-effectiveness, length of hospital stay, mortality
- MeSH terms
- Aged, Anti-Bacterial Agents, Calcitonin, Cross Infection, Female, Humans, Intensive Care Units, Length of Stay, Male, Middle Aged, Protein Precursors, Calcitonin Gene-Related Peptide, Single-Blind Method
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. https://app.cochat.ai/papers/10.1097/ccm.0b013e318251517a
- The paper
- Layios, N., Lambermont, B., Canivet, J.-L., Morimont, P., Preiser, J.-C., Garweg, C., Ledoux, D., Frippiat, F., Piret, S., Giot, J.-B., Wiesen, P., Meuris, C., Massion, P., Leonard, P., Nys, M., Lancellotti, P., Chapelle, J.-P., & Damas, P. (2012). Procalcitonin usefulness for the initiation of antibiotic treatment in intensive care unit patients. Critical Care Medicine. https://doi.org/10.1097/ccm.0b013e318251517a
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.